2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Germ Cell Cancer: new trials by email Literature Review of Germ Cell Cancer trials Research Report on Germ Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors Brentuximab Vedotin - Germ Cell Cancer | Phase 2 | Completed | Fondazione Michelangelo | 9 | 2013-05-01 | 2018-02-07 |
| Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer Everolimus - Testicular Cancer, Germ Cell Cancer | Phase 2 | Completed | Hannover Medical School | 25 | 2010-11-01 | 2015-02-25 |
Neoplasms, Germ Cell and Embryonal (2) · Testicular Neoplasms (2) · Carcinoma, Embryonal (1) · Neoplasm Metastasis (1)
Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Gonadal Disorders (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Testicular Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Neoplastic Processes (1) · Pathologic Processes (1)
Brentuximab Vedotin (1) · Everolimus (1)
Fondazione Michelangelo (1) · Hannover Medical School (1)
Germany (1) · Italy (1)
Alessandro M Gianni, MD (1) · Andrea Necchi, MD (1) · Martin H Fenner, MD (1) · Roberto Salvioni, MD (1)
2009 (1)